Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey-Reference-Cited by-同舟云学术

Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey

Published:2018-09-21 Issue:6 Volume:20 Page:e12982
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Shaffer Ashton A.¹²^ORCID,Thomas Alvin G.¹³^ORCID,Bowring Mary Grace¹^ORCID,Van Pilsum Rasmussen Sarah E.¹^ORCID,Cash Ayla¹^ORCID,Kucirka Lauren M.¹²^ORCID,Alqahtani Saleh A.⁴,Gurakar Ahmet⁴,Sulkowski Mark S.⁴⁵^ORCID,Cameron Andrew M.¹,Segev Dorry L.¹²^ORCID,Durand Christine M.⁵^ORCID

Affiliation:

1. Department of Surgery; Johns Hopkins University School of Medicine; Baltimore Maryland

2. Department of Epidemiology; Johns Hopkins School of Public Health; Baltimore Maryland

3. Department of Epidemiology; University of North Carolina Gillings School of Global Public Health; Chapel Hill North Carolina

4. Department of Hepatology; Johns Hopkins University School of Medicine; Baltimore Maryland

5. Department of Infectious Disease; Johns Hopkins University School of Medicine; Baltimore Maryland

Funder

National Institute of Allergy and Infectious Diseases

National Cancer Institute

National Institute on Drug Abuse

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12982/fullpdf

Reference45 articles.

1. OPTN/SRTR 2013 annual data report: liver;Kim;Am J Transplant,2015

2. An interferon-free antiviral regimen for HCV after liver transplantation;Kwo;N Engl J Med,2014

3. Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: real-world experience from the hepatitis C therapeutic registry and research network;Brown;Liver Transpl,2016

4. Ledipasvir and Sofosbuvir Plus ribavirin for treatment of HCV infection in patients with advanced liver disease;Charlton;Gastroenterology,2015

5. Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C;Fontana;Am J Transplant,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding the liver donor pool worldwide with hepatitis C infected livers, is it the time?;World Journal of Transplantation;2024-06-18

2. Temporal changes in the utilization of kidneys from hepatitis C virus–infected donors in the United States;American Journal of Transplantation;2023-06

3. Willingness of Kidney and Liver Transplant Candidates to Receive HCV-Infected Organs;Journal of Surgical Research;2022-10

4. Use of HCV-Positive Donors into HCV-Negative Solid Organ Transplant Recipients;Textbook of Liver Transplantation;2022

5. Potential donor characteristics and decisions made by organ procurement organization staff: Results of a discrete choice experiment;Transplant Infectious Disease;2021-09-09